A Study of Functional Cognition Following Immunotherapy Cancer Treatment

Tuesday, November 8, 2022

2:15 PM – 3:30 PM

Presenter(s)

Elizabeth Broske, OTD, OTR/L (she/her/hers)

Occupational Therapist
City of Hope
West Chester, Pennsylvania, United States

Slides
Sherry Hite, MOT, OTR/L

Director of Rehabilitation
City of Hope Medical Center
Duarte, California, United States

Neurotoxicity is a known side effect of immunotherapy cancer treatment, which can drastically affect cognitive functioning. Presenters will discuss data from a study which explores changes in cognitive performance and its impact on rehabilitation practices.

Learning Objectives:

Upon completion, participant will be able to have a basic understanding of how cognitive status can fluctuate over the course of immunotherapy treatment
Upon completion, participant will be able to have insight into potential cognitive changes impacting performance that can persist even after discharge from the hospital
Upon completion, participant will be able to explore effective strategies to assess cognition in oncology patients using evidence-based standardized assessment methods
Upon completion, participant will be able to explore the potential impact on rehabilitation practice and future research